Genaera Corp | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Genaera Corp

An SI Board Since August 2003

Posts	SubjectMarks	Bans	Symbol
96	12	0	GENR

Emcee: Matrix_Man	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
46	Thanks for your posts here. Wish there was more activity here since 95% of posts	Dave Mordis	-	6/28/2005
45	Musings on today's PR: Message 21454965	DewDiligence_on_SI	-	6/27/2005
44	<i>And so the stock craters after digesting this news:</i> These we	DewDiligence_on_SI	-	5/7/2005
43	And so the stock craters after digesting this news: <i>Genaera announces	tom pope	-	5/3/2005
42	There’s almost certainly a PIPE coming in the next 1-1.5 months. All of the sign	DewDiligence_on_SI	-	3/5/2005
41	Finally, the stock will move????? <i>Genaera Corporation Announces Positi	tom pope	-	2/25/2005
40	The results even though from a small sample confirm the 40-80mg results of the M	schzammm	-	1/10/2005
39	I hope this has a favorable effect on the stock. I sometimes think GENR could an	tom pope	-	1/10/2005
38	>>PLYMOUTH MEETING, Pa., Jan. 10 /PRNewswire-FirstCall/ -- Genaera Corpora	tuck	-	1/10/2005
37	OFF TOPIC: A heads up on ISA.to, price broke through resistance at C$2.00 this m	schzammm	-	11/2/2004
36	Tom, we all knew that GENR needed an infusion of cash. Personally I was looking	schzammm	-	11/2/2004
35	09:25 ET Genaera announces $13.0 mln direct equity placement (GENR) 3.98: Co ann	tom pope	-	11/2/2004
34	Genaera Receives FDA Fast Track Status for Squalamine in Macular Degeneration b	schzammm	-	10/4/2004
33	About time, this may bring me close to breakeven: Press Release Source: Gen	tom pope	-	10/4/2004
32	Second (SBIR) grant in the last couple days. This one to "develop squalamin	schzammm	-	10/1/2004
31	Uh, oh, just went for the first time to the Yahoo GENR thread and find it's	tom pope	-	9/30/2004
30	There seems to be some pre market activity, but this doesn't seem to be enou	tom pope	-	9/29/2004
29	biz.yahoo.com Genaera Initiates Third Phase II Clinical Trial of Squalamine in	schzammm	-	9/28/2004
28	There is a retina meeting Oct 23 concurrent with the American Academy of New Orl	Dave Mordis	-	9/27/2004
27	<i> No one here?</i> No, I drop in to check on the voices sometimes	Biomaven	-	9/18/2004
26	No one here? That is ok, I have six voices in my head talking most of the time.	schzammm	-	9/16/2004
25	Does anyone else find it interesting that insiders were buying around 8/4/04 and	schzammm	-	8/22/2004
24	Recieved an email Newsletter from the American Academy of Ophthalmology with one	Dave Mordis	-	8/20/2004
23	Genaera Announces Achievement of Clinical Development Milestone by MedImmune, In	schzammm	-	8/18/2004
22	CFO Skolas and two directors bought aggregate 48,956K shares in open market: Al	schzammm	-	8/6/2004

Go to reply# or date (mm/dd/yy):